Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach.
Villalvazo P, Marzal-Alfaro B, García-Alfonso P, Revuelta-Herrero JL, Thomas F, López-Tarruella S, García-González X, Calvo A, Yakoubi M, Salvador-Martín S, López-López F, Aguilar I, Sanjurjo-Sáez M, Martín M, López-Fernández LA. Villalvazo P, et al. Among authors: martin m. J Pers Med. 2021 Aug 13;11(8):792. doi: 10.3390/jpm11080792. J Pers Med. 2021. PMID: 34442436 Free PMC article.
Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.
García-Sáenz JA, Custodio A, Casado A, Vidart JA, Coronado PJ, Martín M, López-Tarruella S, Puente J, Fernández C, Díaz-Rubio E. García-Sáenz JA, et al. Among authors: martin m. Clin Transl Oncol. 2011 Feb;13(2):121-32. doi: 10.1007/s12094-011-0629-6. Clin Transl Oncol. 2011. PMID: 21324801 Review.
Neratinib (HKI-272) in the treatment of breast cancer.
López-Tarruella S, Jerez Y, Márquez-Rodas I, Martín M. López-Tarruella S, et al. Among authors: martin m. Future Oncol. 2012 Jun;8(6):671-81. doi: 10.2217/fon.12.66. Future Oncol. 2012. PMID: 22764764 Review.
Zooming in on the schedule of bone-modifying drugs.
Martin M, López-Tarruella S. Martin M, et al. Lancet Oncol. 2013 Jun;14(7):575-6. doi: 10.1016/S1470-2045(13)70209-2. Epub 2013 May 16. Lancet Oncol. 2013. PMID: 23684410 No abstract available.
Evaluation of a heredofamilial cancer unit in increasing family history collection and genetic counseling referrals among Spanish oncologists at a university hospital.
Márquez-Rodas I, López-Tarruella S, Jerez Y, Cavanagh M, Custodio S, López-Trabada D, Moya B, Pérez S, Rupérez AB, Martín M. Márquez-Rodas I, et al. Among authors: martin m. J Genet Couns. 2014 Feb;23(1):108-13. doi: 10.1007/s10897-013-9617-z. Epub 2013 Jun 16. J Genet Couns. 2014. PMID: 23771728
Bevacizumab in Combination with Capecitabine plus Irinotecan as First-Line Therapy in Metastatic Colorectal Cancer: A Pooled Analysis of 2 Phase II Trials.
García Alfonso P, Muñoz Martin A, Alvarez Suarez S, Blanco Codeidido M, Mondejar Solis R, Tapia Rico G, López Martín P, Martin M. García Alfonso P, et al. Among authors: martin m. Onkologie. 2013;36(6):363-7. doi: 10.1159/000351240. Epub 2013 May 21. Onkologie. 2013. PMID: 23774151 Clinical Trial.
Circulating tumor cells following first chemotherapy cycle: an early and strong predictor of outcome in patients with metastatic breast cancer.
Martín M, Custodio S, de Las Casas ML, García-Sáenz JÁ, de la Torre JC, Bellón-Cano JM, López-Tarruella S, Vidaurreta-Lazaro M, de la Orden V, Jerez Y, Márquez-Rodas I, Casado A, Sastre J, Díaz-Rubio E. Martín M, et al. Oncologist. 2013;18(8):917-23. doi: 10.1634/theoncologist.2012-0479. Epub 2013 Jul 19. Oncologist. 2013. PMID: 23873719 Free PMC article.
12,471 results
You have reached the last available page of results. Please see the User Guide for more information.